The Supreme Court’s observation to mandate generic drug prescriptions could reshape Indian pharma by cutting undue promotional bias and boosting patient-first care.
Generic medicines are bioequivalent, affordable, and accessible, yet often overlooked due to brand incentives.
If well-executed, this shift can: Lower healthcare costs Minimize prescribing bias Empower patients with choices Strengthen trust in healthcare
Generic drugs are good. But in the overall scenario of rampant quakery, and lack of enforcement of disease management protocols, enforcing prescribing generic drugs is just one minor point. Think , like you are forcing a qualified doctor to prescribe ceftriaxone as a generic med and not by brand, but you have a quack sitting next door in the market who has the audacity to scribble down ceftriaxone on a piece of paper and goes out the patient to a chemist across the road, and the chemist hands out him the med without even blinking the eyes.